PHILLIP DETURK: Open Payments
NPI 1275626095 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 74 payments from 8 companies in 2025. Trend: 2023 $1,335 · 2024 $922 · 2025 $1,298
Food & beverage: $1,177Education: $121
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 36 | $382 |
| Galderma Laboratories, L.P. | 8 | $263 |
| ABBVIE INC. | 16 | $250 |
| GENZYME CORPORATION | 6 | $144 |
| UCB, Inc. | 5 | $116 |
| Janssen Biotech, Inc. | 1 | $65 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: NEMLUVIO, SKYRIZI, DUPIXENT, COSENTYX, Bimzelx, TREMFYA, Rhapsido, RINVOQ.
Industry payments across IN — which companies pay providers there.
